PET/MRI's true clinical benefit remains unknown, researchers caution

03/7/2013 | AuntMinnie.com (free registration)

PET/MRI is getting a lot of attention because of its potential to diagnose disease, but experts at a radiology meeting in Vienna advised practitioners to proceed with caution. "Novel imaging technology cannot enter routine clinical practice before diagnostic accuracy, influence on therapeutic management and economic factors have been carefully considered and evidenced by clinical studies," said Dr. Heinz-Peter Schlemmer, head of the radiology department at the German Cancer Research Center. However, despite drawbacks with PET/MRI, such as cost and technical challenges, Schlemmer and colleagues are optimistic that the modality, through research, will eventually prove its worth for cancer patients.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI